Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Derace Schaffer Insider Profile
4 Followers
Derace Schaffer, Director at Altimmune, holds 25.09K shares in Lantheus (Ticker: LNTH), holds 601.85K shares in Altimmune (Ticker: ALT), holds 950.76K shares in American Caresource Holdings (Ticker: GNOW).
Profitable Transactions
4 out of 15 Profitable Transactions
Average Return
-58.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Derace Schaffer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Derace Schaffer
Derace Schaffer's Trading History
Altimmune
Jan 02, 2018
Director
Informative Buy
186.83K
$4.38M
Lantheus
Mar 05, 2020
Director
Uninformative Buy
―
$1.91M
American Caresource Holdings
Jun 18, 2012
Director
Informative Buy
1.24K
$9.51K
List of latest transactions for each holding click on a transaction to see Derace Schaffer's performance on stock
You May Also Like
Derace Schaffer insider profile FAQ
What is the percentage of profitable transactions made by Derace Schaffer?
The percentage of profitable transactions made by Derace Schaffer is 27%.
What is the average return per transaction made by Derace Schaffer?
The average return per transaction made by Derace Schaffer is -58.90%.
What stocks does Derace Schaffer hold?
Derace Schaffer holds: ALT, LNTH, GNOW stocks.
What was Derace Schaffer’s latest transaction?
Derace Schaffer latest transaction was an Uninformative Buy of ―.
What was Derace Schaffer's most profitable transaction?
Derace Schaffer’s most profitable transaction was an Informative Sell of LNTH stock on May 16, 2017. The return on the trade was 11.50%.
What is Derace Schaffer's role in Altimmune?
Derace Schaffer's role in Altimmune is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.